Cargando…
Microtubule-associated protein tau facilitates the targeted killing of proliferating cancer cells in vitro and in a xenograft mouse tumour model in vivo
BACKGROUND: Antibody drug conjugates (ADCs) and immunotoxins (ITs) are promising anticancer immunotherapeutics. Despite their encouraging performance in clinical trials, both ADCs and ITs often suffer from disadvantages such as stoichiometrically undefined chemical linkage of the cytotoxic payload (...
Autores principales: | Hristodorov, D, Mladenov, R, Pardo, A, Pham, A-T, Huhn, M, Fischer, R, Thepen, T, Barth, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776980/ https://www.ncbi.nlm.nih.gov/pubmed/23942071 http://dx.doi.org/10.1038/bjc.2013.457 |
Ejemplares similares
-
CD64-directed microtubule associated protein tau kills leukemic blasts ex vivo
por: Mladenov, Radoslav, et al.
Publicado: (2016) -
Macrophage-Targeted Therapy: CD64-Based Immunotoxins for Treatment of Chronic Inflammatory Diseases
por: Hristodorov, Dmitrij, et al.
Publicado: (2012) -
Angiogenesis in a human neuroblastoma xenograft model: mechanisms and inhibition by tumour-derived interferon-γ
por: Ribatti, D, et al.
Publicado: (2006) -
Fractionated (131)I anti-CEA radioimmunotherapy: effects on xenograft tumour growth and haematological toxicity in mice
por: Violet, J A, et al.
Publicado: (2008) -
The oncolytic effect in vivo of reovirus on tumour cells that have survived reovirus cell killing in vitro
por: Alain, T, et al.
Publicado: (2006)